Skip to search.
 TSX Down 0.61% TSX Ventures Up 0.04%

AstraZeneca PLC (AZN)

-NYSE
67.55 Down 1.35(1.96%) 4:05PM EDT
Add to Portfolio
Prev Close:68.90
Open:68.07
Bid:67.64 x 100
Ask:67.66 x 400
1y Target Est:75.97
Beta:0.88
Next Earnings Date:N/A
Day's Range:66.92 - 68.07
52wk Range:64.26 - 76.57
Volume:2,076,204
Avg Vol (3m):1,220,440
Market Cap:85.38B
P/E (ttm):66.68
EPS (ttm):1.01
Div & Yield:3.80 (5.40%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AZNDown 1.96%85.38B
GSKDown 0.94%107.15B
MRKUp 1.99%172.03B
PFEUp 0.90%213.98B

Key Statistics

Forward P/E (1 yr):16.56
P/S (ttm):3.39
Ex-Dividend Date:18-Feb-15

Analysts

Annual EPS Est (Dec-15) :4.21
Quarterly EPS Est (Jun-15) :1.03
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):5.35

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection, and neuroscience diseases worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback